摘要
目的?探讨特布他林预防咳嗽变异性哮喘复发的临床疗效。方法:将 122 例咳嗽变异性哮喘患儿随机分成观察组 69 例与对照组 53 例,两组常规治疗并应用特布他林 0.65 m g/次, 次 至临床病症消失,观察组在此基础上继续应用特布他林 2 周。结果:复 3 /d发率观察组 8.69% ,对照组 18.89% ,经统计学处理有极显著差异( P < 0.01)。结论:咳嗽变异性哮喘患儿在临床症状体征消失后继续应用特布他林 2 周,对预防复发疗效确切。
Objective: To explore the clinical effect of terbutaline in preventing the asthma recrudesce of variable tussis. Methods: Dividing 122 cases of the syndrome of asthma recrudesce of variable tussis were divided into two groups: one of 69 observed cases and the other of 53 comparative cases. Each group was treated with conventional means with additional tablets of terbutaline (0.65 mg/time, 3 times per day) until the clinical syndrome disappeared. On the basis of this, the observed group was continually treated with terbutaline for other two weeks. Results: The recrudesce rate was 8.69% for the observed group and 18.89% for the comaparative group. Processed with the means of statistics, the results were obviously different (P < 0.01). Conclusions: It is very effective to prevent the recrudesce asthma of variable tussis with terbutaline for 2 more weeks after the clinical syndrome disappears.
出处
《儿科药学杂志》
CAS
2004年第2期33-34,共2页
Journal of Pediatric Pharmacy
